EP3105222 - AROMATIC HETEROCYCLIC COMPOUNDS AS ANTIINFLAMMATORY COMPOUNDS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 15.02.2019 Database last updated on 02.09.2024 | |
Former | The patent has been granted Status updated on 09.03.2018 | ||
Former | Grant of patent is intended Status updated on 17.10.2017 | ||
Former | Request for examination was made Status updated on 18.11.2016 | Most recent event Tooltip | 01.07.2022 | Lapse of the patent in a contracting state New state(s): MK | published on 03.08.2022 [2022/31] | Applicant(s) | For all designated states Respivert Limited 50-100 Holmers Farm Way High Wycombe, Buckinghamshire HP12 4EG / GB | [2017/32] |
Former [2016/51] | For all designated states Respivert Limited 50-100 Holmers Farm Way High Wycombe, Buckinghamshire HP12 4EG / GB | ||
For all designated states Topivert Pharma Limited 265 Strand London WC2R 1BH / GB | Inventor(s) | 01 /
LONGSHAW, Alistair, Ian Sygnature Discovery Ltd Biocity Nottingham Pennyfoot Street Nottingham NG1 1GF / GB | 02 /
FORDYCE, Euan, Alexander, Fraser Sygnature Discovery Ltd Biocity Nottingham Pennyfoot Street Nottingham NG1 1GF / GB | 03 /
ONIONS, Stuart, Thomas Sygnature Discovery Ltd Biocity Nottingham Pennyfoot Street Nottingham NG1 1GF / GB | 04 /
KING-UNDERWOOD, John Moorend Cottage School Lane Pendock Worcestershire GL19 3PW / GB | 05 /
VENABLE, Jennifer, Diane 609 Glencrest Place Solana Beach, California 92075 / US | [2016/51] | Representative(s) | Teuten, Andrew John Sagittarius IP Marlow International Parkway Marlow SL7 1YL / GB | [N/P] |
Former [2016/51] | Teuten, Andrew John Sagittarius IP Three Globeside Fieldhouse Lane Marlow, Buckinghamshire SL7 1HZ / GB | Application number, filing date | 15705797.7 | 13.02.2015 | [2016/51] | WO2015EP53151 | Priority number, date | US201461940282P | 14.02.2014 Original published format: US 201461940282 P | US201461941064P | 18.02.2014 Original published format: US 201461941064 P | [2016/51] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2015121444 | Date: | 20.08.2015 | Language: | EN | [2015/33] | Type: | A1 Application with search report | No.: | EP3105222 | Date: | 21.12.2016 | Language: | EN | The application published by WIPO in one of the EPO official languages on 20.08.2015 takes the place of the publication of the European patent application. | [2016/51] | Type: | B1 Patent specification | No.: | EP3105222 | Date: | 11.04.2018 | Language: | EN | [2018/15] | Search report(s) | International search report - published on: | EP | 20.08.2015 | Classification | IPC: | C07D401/14, A61K31/497, A61P29/00, A61P37/00 | [2016/51] | CPC: |
C07D401/14 (EP,EA,KR,US);
A61K9/0075 (EA,US);
A61K31/215 (EA,KR);
A61K31/4427 (EP,EA,US);
A61K31/497 (EP,EA,KR,US);
A61K31/498 (EP,EA,US);
A61K31/5377 (EP,EA,US);
A61K31/541 (EP,EA,US);
A61K31/551 (EP,EA,US);
A61K45/06 (EA,KR);
A61K47/26 (EA,US);
A61P1/00 (EP,EA);
A61P1/04 (EP,EA);
A61P11/00 (EP,EA);
A61P11/02 (EP,EA);
A61P11/06 (EP,EA);
A61P11/08 (EP,EA);
A61P19/02 (EP,EA);
A61P27/02 (EP,EA);
A61P27/04 (EP,EA);
A61P27/06 (EP,EA);
A61P27/12 (EP,EA);
A61P27/14 (EP,EA);
A61P29/00 (EP,EA);
A61P3/10 (EP,EA);
A61P31/00 (EP,EA);
A61P31/12 (EP,EA);
A61P35/00 (EP,EA);
A61P37/00 (EP,EA);
A61P37/02 (EP,EA);
A61P37/06 (EP,EA);
A61P37/08 (EP,EA);
A61P43/00 (EP,EA);
A61P9/00 (EP,EA);
C07D401/12 (EP,EA,US);
C07D403/14 (EA,KR);
C07D409/14 (EP,EA,KR,US);
C07D413/14 (EP,EA,US);
C07D487/04 (EP,EA,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/51] | Extension states | BA | 12.09.2016 | ME | 12.09.2016 | Title | German: | AROMATISCHE HETEROCYCLISCHE VERBINDUNGEN ALS ENTZÜNDUNGSHEMMENDE VERBINDUNGEN | [2016/51] | English: | AROMATIC HETEROCYCLIC COMPOUNDS AS ANTIINFLAMMATORY COMPOUNDS | [2016/51] | French: | COMPOSÉS HÉTÉROCYCLIQUES AROMATIQUES UTILISÉS EN TANT QUE COMPOSÉS ANTI-INFLAMMATOIRES | [2016/51] | Entry into regional phase | 12.09.2016 | National basic fee paid | 12.09.2016 | Designation fee(s) paid | 12.09.2016 | Examination fee paid | Examination procedure | 12.09.2016 | Examination requested [2016/51] | 12.09.2016 | Date on which the examining division has become responsible | 30.03.2017 | Amendment by applicant (claims and/or description) | 18.10.2017 | Communication of intention to grant the patent | 27.02.2018 | Fee for grant paid | 27.02.2018 | Fee for publishing/printing paid | 27.02.2018 | Receipt of the translation of the claim(s) | Divisional application(s) | EP18161869.5 / EP3357919 | Opposition(s) | 14.01.2019 | No opposition filed within time limit [2019/12] | Fees paid | Renewal fee | 10.02.2017 | Renewal fee patent year 03 | 14.02.2018 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 13.02.2015 | AL | 11.04.2018 | CY | 11.04.2018 | CZ | 11.04.2018 | EE | 11.04.2018 | HR | 11.04.2018 | LT | 11.04.2018 | LV | 11.04.2018 | MC | 11.04.2018 | MK | 11.04.2018 | RO | 11.04.2018 | RS | 11.04.2018 | SI | 11.04.2018 | SK | 11.04.2018 | SM | 11.04.2018 | BG | 11.07.2018 | IS | 11.08.2018 | [2022/31] |
Former [2021/32] | HU | 13.02.2015 | |
AL | 11.04.2018 | ||
CY | 11.04.2018 | ||
CZ | 11.04.2018 | ||
EE | 11.04.2018 | ||
HR | 11.04.2018 | ||
LT | 11.04.2018 | ||
LV | 11.04.2018 | ||
MC | 11.04.2018 | ||
RO | 11.04.2018 | ||
RS | 11.04.2018 | ||
SI | 11.04.2018 | ||
SK | 11.04.2018 | ||
SM | 11.04.2018 | ||
BG | 11.07.2018 | ||
IS | 11.08.2018 | ||
Former [2021/31] | AL | 11.04.2018 | |
CY | 11.04.2018 | ||
CZ | 11.04.2018 | ||
EE | 11.04.2018 | ||
HR | 11.04.2018 | ||
LT | 11.04.2018 | ||
LV | 11.04.2018 | ||
MC | 11.04.2018 | ||
RO | 11.04.2018 | ||
RS | 11.04.2018 | ||
SI | 11.04.2018 | ||
SK | 11.04.2018 | ||
SM | 11.04.2018 | ||
BG | 11.07.2018 | ||
IS | 11.08.2018 | ||
Former [2021/26] | AL | 11.04.2018 | |
CY | 11.04.2018 | ||
CZ | 11.04.2018 | ||
EE | 11.04.2018 | ||
HR | 11.04.2018 | ||
LT | 11.04.2018 | ||
LV | 11.04.2018 | ||
MC | 11.04.2018 | ||
RO | 11.04.2018 | ||
RS | 11.04.2018 | ||
SI | 11.04.2018 | ||
SK | 11.04.2018 | ||
SM | 11.04.2018 | ||
BG | 11.07.2018 | ||
Former [2019/45] | AL | 11.04.2018 | |
CZ | 11.04.2018 | ||
EE | 11.04.2018 | ||
HR | 11.04.2018 | ||
LT | 11.04.2018 | ||
LV | 11.04.2018 | ||
MC | 11.04.2018 | ||
RO | 11.04.2018 | ||
RS | 11.04.2018 | ||
SI | 11.04.2018 | ||
SK | 11.04.2018 | ||
SM | 11.04.2018 | ||
BG | 11.07.2018 | ||
Former [2019/26] | AL | 11.04.2018 | |
CZ | 11.04.2018 | ||
EE | 11.04.2018 | ||
HR | 11.04.2018 | ||
LT | 11.04.2018 | ||
LV | 11.04.2018 | ||
RO | 11.04.2018 | ||
RS | 11.04.2018 | ||
SI | 11.04.2018 | ||
SK | 11.04.2018 | ||
SM | 11.04.2018 | ||
BG | 11.07.2018 | ||
Former [2019/11] | AL | 11.04.2018 | |
CZ | 11.04.2018 | ||
EE | 11.04.2018 | ||
HR | 11.04.2018 | ||
LT | 11.04.2018 | ||
LV | 11.04.2018 | ||
RO | 11.04.2018 | ||
RS | 11.04.2018 | ||
SK | 11.04.2018 | ||
SM | 11.04.2018 | ||
BG | 11.07.2018 | ||
Former [2019/10] | AL | 11.04.2018 | |
CZ | 11.04.2018 | ||
EE | 11.04.2018 | ||
HR | 11.04.2018 | ||
LT | 11.04.2018 | ||
LV | 11.04.2018 | ||
RO | 11.04.2018 | ||
RS | 11.04.2018 | ||
SK | 11.04.2018 | ||
BG | 11.07.2018 | ||
Former [2019/09] | AL | 11.04.2018 | |
EE | 11.04.2018 | ||
HR | 11.04.2018 | ||
LT | 11.04.2018 | ||
LV | 11.04.2018 | ||
RS | 11.04.2018 | ||
BG | 11.07.2018 | ||
Former [2018/51] | AL | 11.04.2018 | |
HR | 11.04.2018 | ||
LT | 11.04.2018 | ||
LV | 11.04.2018 | ||
RS | 11.04.2018 | ||
BG | 11.07.2018 | ||
Former [2018/50] | AL | 11.04.2018 | |
HR | 11.04.2018 | ||
LT | 11.04.2018 | ||
BG | 11.07.2018 | ||
Former [2018/46] | AL | 11.04.2018 | |
LT | 11.04.2018 | Cited in | International search | [AD]WO0043384 (BOEHRINGER INGELHEIM PHARMA [US]) [AD] 1-18 * claims 1,16 *; | [AD]WO2010112936 (RESPIVERT LTD [GB], et al) [AD] 1-16* claims 1,5 *; | [A]WO2011124923 (RESPIVERT LTD [GB], et al) [A] 1-18 * claims 1,35 *; | [A]WO2013050757 (RESPIVERT LTD [GB]) [A] 1-18 * claims 1, 12 * | by applicant | WO0043384 | WO2010067131 | WO2010112936 | WO2011070369 | WO2011158039 | - O'KEEFE, S.J. ET AL., J. BIOL. CHEM., (2007), vol. 282, no. 48, pages 34663 - 71 | - FITZSIMMONS, B.L. ET AL., NEUROREPORT, (2010), vol. 21, no. 4, pages 313 - 7 | - PETTUS, L.H.; WURZ, R.P., CURR. TOP. MED. CHEM., (2008), vol. 8, no. 16, pages 1452 - 67 | - GENOVESE ET AL., J. RHEUMATOL., (2011), vol. 38, pages 846 - 54 | - PAMAPIMOD, COHEN ET AL., ARTHRITIS RHEUM., (2009), vol. 60, pages 335 - 344 | - SCHIEVEN ET AL., ARTHRITIS RHEUM., (2010), vol. 62, no. 10, page 1513 | - LOSMAPIMOD, WATZ ET AL., LANCET RESP. MED., (2014), vol. 2, pages 63 - 72 | - SCHREIBER, S. ET AL., CLIN. GASTRO. HEPATOLOGY, (2006), vol. 4, pages 325 - 334 | - SHMUELI, O. ET AL., COMPTES RENDUS BIOLOGIES, (2003), vol. 326, no. 10-11, pages 1067 - 1072 | - SMITH, S. J., BR. J. PHARMACOL., (2006), vol. 149, pages 393 - 404 | - HALE, K. K., J. IMMUNOL., (1999), vol. 162, no. 7, pages 4246 - 52 | - WANG, X. S. ET AL., J. BIOL. CHEM., (1997), vol. 272, no. 38, pages 23668 - 23674 | - COURT, N. W. ET AL., J. MOL. CELL. CARDIOL., (2002), vol. 34, no. 4, pages 413 - 26 | - MERTENS, S. ET AL., FEBS LETT., (1996), vol. 383, no. 3, pages 273 - 6 | - KUMA, Y., J. BIOL. CHEM., (2005), vol. 280, pages 19472 - 19479 | - CHUNG, F., CHEST, (2011), vol. 139, no. 6, pages 1470 - 1479 | - SMITH ET AL., BR. J. PHARMACOL., (2006), vol. 149, pages 393 - 404 | - RISCO ET AL., PROC. NATL. ACAD. SCI. U.S.A., (2012), vol. 109, pages 11200 - 11205 | - CRIADO, G. ET AL., ARTHRITIS RHEUM., (2014), vol. 66, no. 5, pages 1208 - 17 | - SMITH, S.J., BR. J. PHARMACOL., (2006), vol. 149, pages 393 - 404 | - UNDERWOOD, D.C. ET AL., AM. J. PHYSIOL., (2000), vol. 279, pages L895 - 902 | - NATH, P. ET AL., EUR. J. PHARMACOL., (2006), vol. 544, pages 160 - 167 | - IRUSEN, E. ET AL., J. ALLERGY CLIN. IMMUNOL., (2002), vol. 109, pages 649 - 657 | - LEE, M.R.; DOMINGUEZ, C., CURRENT MED. CHEM., (2005), vol. 12, pages 2979 - 2994 | - MERCADO, N. ET AL., MOL. PHARMACOL., (2011), vol. 80, no. 6, pages 1128 - 1135 | - MERCADO, N. ET AL., PLOS ONE, (2012), vol. 7, no. 7, pages E41582,1 - 9 | - PAPI ET AL., J. ALLERGY CLIN. IMMUNOL., (2013), vol. 132, pages 1075 - 1085 | - ARMSTRONG ET AL., JPET, (2011), vol. 338, pages 732 - 740 | - PAPADOPOULOS, N.G. ET AL., PAEDIATR. RESPIR. REV., (2004), vol. 5, no. 3, pages 255 - 260 | - GRUNBERG, K. ET AL., AM. J. RESPIR. CRIT. CARE MED., (2001), vol. 164, no. 10, pages 1816 - 1822 | - WAT, D. ET AL., J. CYST. FIBROS., (2008), vol. 7, pages 320 - 328 | - LIU, M. ET AL., TRANSPL. INFECT. DIS., (2009), vol. 11, no. 4, pages 304 - 312 | - WANG ET AL., J. IMMUNOL., (2009), vol. 183, pages 6989 - 6997 | - MAHMUTOVIC-PERSSON ET AL., ALLERGY, (2014), vol. 69, no. 3, pages 348 - 358 | - WANG, Q. ET AL., PLOS PATHOG., vol. 7, no. 5, page E1002070 | - LAU ET AL., J. IMMUNOL., (2008), vol. 180, pages 870 - 880 | - BENTLEY, J.K. ET AL., J. VIROL., (2007), vol. 81, pages 1186 - 1194 | - INOUE, D. ET AL., RESPIR. PHYSIOL. NEUROBIOL., (2006), vol. 154, no. 3, pages 484 - 499 | - SHILO, Y., NAT. REV. CANCER, (2003), vol. 3, pages 155 - 168 | - OLAHARSKY, A.J. ET AL., PLOS COMPUT. BIOL., (2009), vol. 5, no. 7, page E1000446 | - TIGHE, A. ET AL., BMC CELL BIOLOGY, (2007), vol. 8, page 34 | - SURRY, D.S.; BUCHWALD, S.L., "Biaryl Phosphane Ligands in Palladium-Catalyzed Amination", ANGEW. CHEM. INT. ED., (2008), vol. 47, pages 6338 - 6361 | - SWAMY, K. C.; KUMAR, N. N.; BALARAMAN, E.; KUMAR, K. V., "Mitsunobu and Related Reactions: Advances and Applications", CHEMICAL REVIEWS, (2009), vol. 109, no. 6, doi:doi:10.1021/cr800278z, pages 2551 - 2651, XP055023394 DOI: http://dx.doi.org/10.1021/cr800278z |